FDA Cardiovascular Devices Research Fellowship

U.S. Food and Drug Administration (FDA)

FDA-CDRH-

All documents must be in English or include an official English translation.

If you have questions, send an email to ORISE.FDA.CDRH / . Please include the reference code for this opportunity in your email.

Connect with ORISE on the GO! Download the new ORISE GO mobile app in the Apple App Store or Google Play Store to help you stay engaged, connected, and informed during your ORISE experience and beyond!

9/30/2027 3:00:00 PM Eastern Time Zone

• Applications will be reviewed on a rolling-basis.

A research opportunity is available within the Center for Devices and Radiological Health (CDRH), Food and Drug Administration (FDA), located at Silver Spring, Maryland.

The FDA's CDRH Cardiovascular Program conducts regulatory science research to ensure safe and effective cardiovascular devices like stents, pacemakers, and heart valves that have benefited millions of patients. The program addresses critical gaps including lack of credible preclinical blood damage assessment methods, over reliance on clinical data for device performance evaluation, durability issues in implants, and insufficient tools for predicting clinical outcomes.

To fill these gaps, the program develops in vitro, in vivo, and computational models for comprehensive device evaluation. Research focuses on four areas: hemocompatibility testing for blood damage, hemodynamics assessment under simulated conditions, device durability evaluation, and electrophysiology methods for cardiac device safety.

Under the guidance of an FDA mentor, you will learn?:

• Design and fabrication of samples and fixtures in CAD (e.g., Solid Works)
• Development of computational models and conduct simulations (e.g., ANSYS, Abaqus)
• How to perform bench testing or characterization methodologies (e.g., mechanical, blood damage)
• Programming (e.g., Python, g-code)
• Data analysis
• Statistical analyses
• How to create reports

The mentor for this opportunity is Prasanna Hariharan (Prasanna.Hariharan.gov). If you have questions about the nature of the research, please contact the mentor.

2026.

The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.

The appointment is full time.

The participant will receive a monthly stipend commensurate with educational level and experience.

This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page of the program website for information about the valid immigration statuses that are acceptable for program participation.

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.

Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded  can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.

If an ORISE Fellow, to include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate the relationship, then the individual is not placed  additional requirements, see FDA Ethics for Nonemployee Scientists.

FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such…